tetano
Editor, Senior Moderator
J Virol
. 2024 Dec 5:e0169524.
doi: 10.1128/jvi.01695-24. Online ahead of print. Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model
Huibin Lv[SUP] 1 2 3 [/SUP], Qi Wen Teo[SUP] 1 2 3 [/SUP], Chang-Chun D Lee[SUP] 4 [/SUP], Weiwen Liang[SUP] 3 5 [/SUP], Danbi Choi[SUP] 2 [/SUP], Kevin J Mao[SUP] 2 [/SUP], Madison R Ardagh[SUP] 2 [/SUP], Akshita B Gopal[SUP] 2 [/SUP], Arjun Mehta[SUP] 2 [/SUP], Matt Szlembarski[SUP] 2 [/SUP], Roberto Bruzzone[SUP] 3 5 6 [/SUP], Ian A Wilson[SUP] 4 7 [/SUP], Nicholas C Wu[SUP] 1 2 8 9 [/SUP], Chris K P Mok[SUP] 10 11 12 13 [/SUP]
Affiliations
Understanding how immune history influences influenza immunity is essential for developing effective vaccines and therapeutic strategies. This study examines the antigenic imprinting of influenza hemagglutinin (HA) and neuraminidase (NA) using a mouse model with sequential infections by H1N1 virus strains exhibiting substantial antigenic differences in HA. In our pre-2009 influenza infection model, we observed that mice with more extensive infection histories produced higher levels of functional NA-inhibiting antibodies (NAI). However, following further infection with the 2009 pandemic H1N1 strain, these mice demonstrated a reduced NAI to the challenged virus. Interestingly, prior exposure to older strains resulted in a lower HA antibody response (neutralization and HAI) to the challenged virus in both pre- and post-2009 scenarios, potentially due to faster viral clearance facilitated by immune memory recall. Overall, our findings reveal distinct trajectories in HA and NA immune responses, suggesting that immune imprinting can differentially impact these proteins based on the extent of antigenic variation in influenza viruses.
Importance: Influenza viruses continue to pose a significant threat to human health, with vaccine effectiveness remaining a persistent challenge. Individual immune history is a crucial factor that can influence antibody responses to subsequent influenza exposures. While many studies have explored how pre-existing antibodies shape the induction of anti-HA antibodies following influenza virus infections or vaccinations, the impact on anti-NA antibodies has been less extensively studied. Using a mouse model, our study demonstrates that within pre-2009 H1N1 strains, an extensive immune history negatively impacted anti-HA antibody responses but enhanced anti-NA antibody responses. However, in response to the 2009 pandemic H1N1 strain, which experienced an antigenic shift, both anti-HA and anti-NA antibody responses were hindered by antibodies from prior pre-2009 H1N1 virus infections. These findings provide important insights into how antigenic imprinting affects both anti-HA and anti-NA antibody responses and underscore the need to consider immune history in developing more effective influenza vaccination strategies.
Keywords: antigenic imprinting; hemagglutinin (HA); immune history; neuraminidase (NA).
. 2024 Dec 5:e0169524.
doi: 10.1128/jvi.01695-24. Online ahead of print. Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model
Huibin Lv[SUP] 1 2 3 [/SUP], Qi Wen Teo[SUP] 1 2 3 [/SUP], Chang-Chun D Lee[SUP] 4 [/SUP], Weiwen Liang[SUP] 3 5 [/SUP], Danbi Choi[SUP] 2 [/SUP], Kevin J Mao[SUP] 2 [/SUP], Madison R Ardagh[SUP] 2 [/SUP], Akshita B Gopal[SUP] 2 [/SUP], Arjun Mehta[SUP] 2 [/SUP], Matt Szlembarski[SUP] 2 [/SUP], Roberto Bruzzone[SUP] 3 5 6 [/SUP], Ian A Wilson[SUP] 4 7 [/SUP], Nicholas C Wu[SUP] 1 2 8 9 [/SUP], Chris K P Mok[SUP] 10 11 12 13 [/SUP]
Affiliations
- PMID: 39636110
- DOI: 10.1128/jvi.01695-24
Understanding how immune history influences influenza immunity is essential for developing effective vaccines and therapeutic strategies. This study examines the antigenic imprinting of influenza hemagglutinin (HA) and neuraminidase (NA) using a mouse model with sequential infections by H1N1 virus strains exhibiting substantial antigenic differences in HA. In our pre-2009 influenza infection model, we observed that mice with more extensive infection histories produced higher levels of functional NA-inhibiting antibodies (NAI). However, following further infection with the 2009 pandemic H1N1 strain, these mice demonstrated a reduced NAI to the challenged virus. Interestingly, prior exposure to older strains resulted in a lower HA antibody response (neutralization and HAI) to the challenged virus in both pre- and post-2009 scenarios, potentially due to faster viral clearance facilitated by immune memory recall. Overall, our findings reveal distinct trajectories in HA and NA immune responses, suggesting that immune imprinting can differentially impact these proteins based on the extent of antigenic variation in influenza viruses.
Importance: Influenza viruses continue to pose a significant threat to human health, with vaccine effectiveness remaining a persistent challenge. Individual immune history is a crucial factor that can influence antibody responses to subsequent influenza exposures. While many studies have explored how pre-existing antibodies shape the induction of anti-HA antibodies following influenza virus infections or vaccinations, the impact on anti-NA antibodies has been less extensively studied. Using a mouse model, our study demonstrates that within pre-2009 H1N1 strains, an extensive immune history negatively impacted anti-HA antibody responses but enhanced anti-NA antibody responses. However, in response to the 2009 pandemic H1N1 strain, which experienced an antigenic shift, both anti-HA and anti-NA antibody responses were hindered by antibodies from prior pre-2009 H1N1 virus infections. These findings provide important insights into how antigenic imprinting affects both anti-HA and anti-NA antibody responses and underscore the need to consider immune history in developing more effective influenza vaccination strategies.
Keywords: antigenic imprinting; hemagglutinin (HA); immune history; neuraminidase (NA).